Management of Fungal Infections
Treatment Options
- The Infectious Diseases Society of America recommends considering Amphotericin B deoxycholate 1 mg/kg daily for systemic infection if no improvement after 3 days of topical therapy, and Fluconazole 12 mg/kg daily if no prior fluconazole exposure 1
- Oral nystatin suspension is recommended at a dose of 1 mL (100,000 units) four times daily for at least 48 hours after symptoms resolve, particularly if there is concurrent oral thrush 2
- Fluconazole may be considered if nystatin fails or in severe cases, at a dosage of 3 mg/kg once daily for 7 days, but is reserved as second-line due to concerns about developing triazole resistance 2
- Echinocandins should be used with caution in infants and generally limited to salvage therapy 1
Monitoring and Diagnosis
- Monitor for signs of systemic infection, especially in premature or low birth weight infants, including persistent fever, feeding intolerance, lethargy, and persistent positive cultures 1, 3
- If systemic infection is suspected, perform blood cultures, lumbar puncture, and urine culture, and consider imaging of genitourinary tract, liver, and spleen 1
Systemic Infection Management
- The Infectious Diseases Society of America recommends initiating systemic antifungal therapy promptly, and continuing therapy for 2 weeks after documented clearance of Candida from bloodstream 1
- The American Academy of Pediatrics recommends keeping the area clean and dry, and addressing the underlying cause of gastroesophageal reflux and vomiting to prevent candidal rash in infants 2
- The Centers for Disease Control and Prevention suggests that topical nystatin is effective against various Candida species, including C. albicans, which is the most common cause of candidal rash in infants 2
Special Considerations
- Premature or low birth weight infants with candidal rash require more vigilant monitoring as they are at higher risk for invasive candidiasis 3
- In premature neonates, cutaneous candidiasis can potentially become invasive and lead to disseminated disease, and for infants with extensive rash or signs of systemic involvement, consider systemic antifungal therapy 4
Treatment Evaluation and Common Mistakes
- Evaluate response to therapy after 2-3 days of treatment, and if no improvement is seen, consider reassessing the diagnosis, checking for proper medication application technique, evaluating for potential sources of reinfection, and considering alternative antifungal agents 2
- Common mistakes to avoid in the treatment of candidal rash in infants include inadequate drying after cleaning, insufficient treatment duration, failure to address underlying reflux, missing concurrent oral thrush, and using occlusive barrier creams 2